NCT02552303View on ClinicalTrials.gov

The Treatment of Insomnia Comorbid With Sleep Disordered Breathing Using Armodafinil and/or Cognitive Behavioral Therapy for Insomnia

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions

Sleep ApneaInsomnia

Interventions

BEHAVIORAL

Cognitive Behavioral Therapy for Insomnia

Cognitive Behavioral Therapy for Insomnia.

DRUG

Armodafinil

Active medication

DRUG

Placebo

Placebo for Nuvigil (armodafinil)

All Listed Sponsors

collaborator

Teva Pharmaceutical Industries, Ltd.

INDUSTRY

lead

University of Pennsylvania

OTHER

NCT02552303 - The Treatment of Insomnia Comorbid With Sleep Disordered Breathing Using Armodafinil and/or Cognitive Behavioral Therapy for Insomnia | Biotech Hunter | Biotech Hunter